Interact to see
Advertisement
Advertisement
FAFGX vs MRLTX
FAFGX vs MRLTX Comparison
Open Charts FAFGX vs MRLTX
American Funds Growth Fund of Amer 529F2
Price$83.24
Change-$0.27 (-0.32%)
VolumeN/A
Net Assets324.16B
AMG Renaissance Large Cap Growth N
Price$18.97
Change-$0.03 (-0.16%)
VolumeN/A
Net Assets138.27M
FAFGX vs MRLTX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
FUNDAMENTALS
Fundamentals
FAFGX has more cash in the bank: 324B vs. MRLTX (138M). FAFGX pays higher dividends than MRLTX: FAFGX (0.53) vs MRLTX (0.00). FAFGX was incepted earlier than MRLTX: FAFGX (5 years) vs MRLTX (16 years). MRLTX (1.11) is less costly to investors than FAFGX (0.40). MRLTX is a more actively managed with annual turnover of: 47.00 vs. FAFGX (25.00). FAFGX has a lower initial minimum investment than MRLTX: FAFGX (250) vs MRLTX (2000). FAFGX annual gain was more profitable for investors over the last year : 14.23 vs. MRLTX (4.00).
| FAFGX | MRLTX | FAFGX / MRLTX | |
| Total Expense Ratio | 0.40 | 1.00 | 40% |
| Annual Report Gross Expense Ratio | 0.40 | 1.11 | 36% |
| Fund Existence | 5 years | 16 years | - |
| Gain YTD | 12.381 | 6.383 | 194% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 2000 | 13% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 324B | 138M | 234,783% |
| Annual Yield % from dividends | 0.53 | 0.00 | - |
| Returns for 1 year | 14.23 | 4.00 | 356% |
| Returns for 3 years | 56.02 | 26.57 | 211% |
| Returns for 5 years | N/A | 36.03 | - |
| Returns for 10 years | N/A | 66.96 | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MIDLX | 34.45 | 0.19 | +0.55% |
| MFS International New Discovery R6 | |||
| RMATX | 11.42 | 0.04 | +0.35% |
| Russell Inv Multi-Asset Strat M | |||
| RYMSX | 24.54 | 0.03 | +0.12% |
| Guggenheim Multi-Hedge Strategies P | |||
| DPLGX | 28.23 | -0.03 | -0.11% |
| Jackson Square Large-Cap Growth IS | |||
| LGOAX | 41.95 | -0.05 | -0.12% |
| Patient Opportunity A | |||